USPTO serial 88472660
INVETECH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 11, 2020
- Examiner
- HILLIARD, JESSICA LYNN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with INVETECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mt. Waverley Victoria, AU
Mt. Waverley Victoria, AU
Mt. Waverley Victoria, AU
Mt. Waverley Victoria, AU
Mt. Waverley Victoria, AU
Mt. Waverley Victoria, AU
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 037 | Installation, cleaning, repair and maintenance of scientific and medical devices for others; installation, cleaning, repair and maintenance of biomedical and scientific instrumentation, computer hardware and factory automation machinery in the fields of healthcare, biomedical, life sciences and cell and advanced therapies; providing advice, consultancy and information with regard to the aforesaid services | ACTIVE | — |
| 040 | Custom manufacture and assembly services, namely, custom manufacture and assembly of biomedical and scientific instrumentation; custom construction and manufacture of biomedical and scientific instrumentation; custom construction and manufacture of scientific and medical devices for others; custom construction and manufacture of biomedical and scientific instrumentation and computer hardware for use with biomedical and scientific instrumentation; custom construction and manufacturing in the fields of healthcare, biomedical, life sciences and cell and advanced therapies, namely, custom construction and manufacture of biomedical and scientific instrumentation for others; providing advice, consultancy and information with regard to the aforesaid services | ACTIVE | — |
| 042 | Science and technology services, namely, scientific research in the fields of diagnostics and life sciences, point of care diagnostics, and cell and advanced therapies; consultancy services, namely, technical consultancy in the fields of diagnostics and life sciences, point of care diagnostics, and cell and advanced therapies; engineering services; design and development services, namely, design and development of biomedical and scientific instrumentation; computer hardware development for biomedical and scientific instrumentation products; software design, development, programming and implementation in the fields of biomedical and scientific instrumentation; IT consulting services in the nature of IT consultancy, advisory and information services in the fields of biomedical and scientific instrumentation; Software as a Service (SAAS) services featuring software for database management in the fields of diagnostics and life sciences, point of care diagnostics, and cell and advanced therapies; scientific and technological consultancy services, namely, technological consulting services in the fields of diagnostics and life sciences technologies, point of care diagnostics technologies, and cell and advanced therapies technologies; consultancy services relating to design, development and engineering, namely, consulting services in the field of design and development of engineering processes in the fields of diagnostics and life sciences, point of care diagnostics, and cell and advanced therapies; consultancy services relating to the design, development, engineering, custom construction and manufacture of scientific and medical devices, and biomedical and scientific instrumentation, computer hardware and factory automation machinery for use in the fields of diagnostics and life sciences, point of care diagnostics, and cell and advanced therapies; Consulting services in the field of medical physics, namely, consultancy services in the fields of healthcare, biomedical, life sciences and cell and advanced therapies; scientific and technological engineering services in the fields of diagnostics and life sciences, point of care diagnostics, and cell and advanced therapies; engineering services in relation to scientific and medical devices, biomedical and scientific instrumentation and computer hardware and factory automation related to diagnostics and life sciences, point of care diagnostics, and cell and advanced therapies; engineering services in the fields of healthcare, biomedical, life sciences and cell and advanced therapies; scientific and technological design and development services, namely, design and development of computer software for operating biomedical and scientific instrumentation products; custom design and development services, namely, custom design and development of computer software for operating biomedical and scientific instrumentation products; process design and development services, namely, consulting services in the field of design and development of engineering processes for diagnostics and life sciences, point of care diagnostics, and cell and advanced therapies; product design and development in the fields of diagnostics and life sciences, point of care diagnostics, and cell and advanced therapies; product design and development of biomedical and scientific instrumentation; product design and development in the fields of healthcare, biomedical, life sciences and cell and advanced therapies; computer programming in the fields of healthcare, biomedical, life sciences and cell and advanced therapies; computer programming consultancy in the fields of healthcare, biomedical, life sciences and cell and advanced therapies; computer programming services relating to design, development and engineering in the fields of healthcare, biomedical, life sciences and cell and advanced therapies; computer programming services in the fields of healthcare, biomedical, life sciences and cell and advanced therapies; design, development, implementation, maintenance, updating and repair of computer software used in the fields of healthcare, biomedical, life sciences and cell and advanced therapies; design, development, installation, maintenance, updating and repair of computer software relating to the design, development, engineering, custom construction and manufacture of scientific and medical devices and related computer hardware and factory automation; design, development, installation, maintenance, updating and repair of computer software in the fields of healthcare, biomedical, life sciences, and cell and advanced therapies; computer software consultancy services in the fields of healthcare, biomedical, life sciences and cell and advanced therapies; providing advice, consultancy and information with regard to the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Invetech Pty Ltd
- Other trademarks owned by Invetech Pty Ltd
- Other trademarks owned by Invetech Pty Ltd
- Other trademarks owned by Invetech Pty Ltd
- Other trademarks owned by Invetech Pty Ltd
- Other trademarks owned by Invetech Pty Ltd
- Other trademarks in Class 037
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named INVETECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 11, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Aug 14, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 14, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 14, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 14, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 14, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 11, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 15, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 15, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Nov 15, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 15, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 11, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 26, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 26, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 26, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 26, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 26, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 6, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 22, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 16, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 16, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 15, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 10, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 10, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 10, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 21, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 9, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 5, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 5, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 5, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 5, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 11, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 26, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 17, 2019 | NWAP | NEW APPLICATION ENTERED | — |